These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19790235)

  • 1. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
    Vander Griend DJ; D'Antonio J; Gurel B; Antony L; Demarzo AM; Isaacs JT
    Prostate; 2010 Jan; 70(1):90-9. PubMed ID: 19790235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.
    Vander Griend DJ; Litvinov IV; Isaacs JT
    Int J Biol Sci; 2014; 10(6):627-42. PubMed ID: 24948876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
    Gao J; Isaacs JT
    Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.
    Sun F; Chen HG; Li W; Yang X; Wang X; Jiang R; Guo Z; Chen H; Huang J; Borowsky AD; Qiu Y
    J Biol Chem; 2014 Jan; 289(3):1529-39. PubMed ID: 24297183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
    Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
    Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer stem cells: do they have a basal or luminal phenotype?
    Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT
    Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion.
    Li Y; Li CX; Ye H; Chen F; Melamed J; Peng Y; Liu J; Wang Z; Tsou HC; Wei J; Walden P; Garabedian MJ; Lee P
    J Cell Mol Med; 2008 Dec; 12(6B):2790-8. PubMed ID: 18266956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
    Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.
    Chen S; Principessa L; Isaacs JT
    Prostate; 2012 Sep; 72(13):1478-89. PubMed ID: 22396312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
    Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
    J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.
    Tahsin S; Sane NS; Cernyar B; Jiang L; Zohar Y; Lee BR; Miranti CK
    Oncogene; 2024 Jun; 43(27):2092-2103. PubMed ID: 38769192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.